Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 9 2023 | FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients Industry News Industry Read More Apr 26 2023 | Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Industry News In The News Industry Read More Apr 20 2023 | New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure Industry News In The News Industry Read More Mar 31 2023 | Cytokinetics Releases Inaugural Corporate Responsibility Report Industry News In The News Industry Read More Mar 23 2023 | Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
May 9 2023 | FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients Industry News Industry Read More
Apr 26 2023 | Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Industry News In The News Industry Read More
Apr 20 2023 | New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure Industry News In The News Industry Read More
Mar 31 2023 | Cytokinetics Releases Inaugural Corporate Responsibility Report Industry News In The News Industry Read More
Mar 23 2023 | Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients Industry News In The News Industry Read More
